Global Digital Pathology AI-Assisted Diagnostic System Supply, Demand and Key Producers, 2026-2032
The global Digital Pathology AI-Assisted Diagnostic System market size is expected to reach $ 1762 million by 2032, rising at a market growth of 11.3% CAGR during the forecast period (2026-2032).
The Digital Pathology AI-Assisted Diagnostic System is a technology-driven platform that integrates artificial intelligence (AI) with digital pathology to aid in the analysis and diagnosis of pathological samples. This system employs AI algorithms to analyze high-resolution digital images of tissue samples, assisting pathologists in detecting, classifying, and quantifying abnormalities, such as cancerous or precancerous changes. It improves diagnostic accuracy, speeds up the analysis process, and enhances the workflow in pathology labs, ultimately supporting early disease detection and personalized treatment planning.
The value chain starts with slide preparation (tissue processing, staining) and scanner OEMs that generate WSI, followed by infrastructure providers (storage, compute, security) and software vendors delivering viewers, PACS/LIS connectors, and AI modules. Upstream enablers include data annotation services, clinical partners, and regulatory/quality systems. Downstream, customers are hospital pathology departments, reference labs, cancer centers, and increasingly pharmaceutical companies using digital pathology for biomarker research and trial operations. Integration partners (LIS vendors, digital pathology platform providers, and system integrators) often influence procurement, because switching costs are driven by workflow redesign, validation burden, and data migration.
Cost structure is software-heavy: R&D (model training, validation studies), regulatory/quality compliance, and post-market surveillance dominate fixed costs; variable costs come from cloud compute, storage, customer support, and implementation. Gross margins can be attractive for mature products (software economics), but early-stage vendors may see margin dilution from heavy services (data onboarding, scanner interoperability testing, site validation). Transaction details commonly involve pilots (3?6 months), performance benchmarks on local cases, cybersecurity reviews, and multi-year contracts with add-ons (additional algorithms, seats, sites). Market trends include faster adoption of end-to-end digital workflows, expansion from single-organ tools to multi-cancer suites, tighter regulatory expectations, and convergence with multimodal diagnostics (WSI + genomics + clinical data) to improve risk stratification and treatment selection.
This report studies the global Digital Pathology AI-Assisted Diagnostic System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Digital Pathology AI-Assisted Diagnostic System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Digital Pathology AI-Assisted Diagnostic System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Digital Pathology AI-Assisted Diagnostic System total market, 2021-2032, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Digital Pathology AI-Assisted Diagnostic System total market, key domestic companies, and share, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by Type, CAGR, 2021-2032, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Digital Pathology AI-Assisted Diagnostic System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lunit, VUNO, Inc., Konfoong Bioinformation Tech, Techcyte, Hologic, Canon Medical, ANNALISE-AI PTY LTD, CellsVision, Dipath, Cytowiz Incorporated, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Digital Pathology AI-Assisted Diagnostic System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Digital Pathology AI-Assisted Diagnostic System Market, By Region:
1. How big is the global Digital Pathology AI-Assisted Diagnostic System market?
2. What is the demand of the global Digital Pathology AI-Assisted Diagnostic System market?
3. What is the year over year growth of the global Digital Pathology AI-Assisted Diagnostic System market?
4. What is the total value of the global Digital Pathology AI-Assisted Diagnostic System market?
5. Who are the Major Players in the global Digital Pathology AI-Assisted Diagnostic System market?
6. What are the growth factors driving the market demand?
The Digital Pathology AI-Assisted Diagnostic System is a technology-driven platform that integrates artificial intelligence (AI) with digital pathology to aid in the analysis and diagnosis of pathological samples. This system employs AI algorithms to analyze high-resolution digital images of tissue samples, assisting pathologists in detecting, classifying, and quantifying abnormalities, such as cancerous or precancerous changes. It improves diagnostic accuracy, speeds up the analysis process, and enhances the workflow in pathology labs, ultimately supporting early disease detection and personalized treatment planning.
The value chain starts with slide preparation (tissue processing, staining) and scanner OEMs that generate WSI, followed by infrastructure providers (storage, compute, security) and software vendors delivering viewers, PACS/LIS connectors, and AI modules. Upstream enablers include data annotation services, clinical partners, and regulatory/quality systems. Downstream, customers are hospital pathology departments, reference labs, cancer centers, and increasingly pharmaceutical companies using digital pathology for biomarker research and trial operations. Integration partners (LIS vendors, digital pathology platform providers, and system integrators) often influence procurement, because switching costs are driven by workflow redesign, validation burden, and data migration.
Cost structure is software-heavy: R&D (model training, validation studies), regulatory/quality compliance, and post-market surveillance dominate fixed costs; variable costs come from cloud compute, storage, customer support, and implementation. Gross margins can be attractive for mature products (software economics), but early-stage vendors may see margin dilution from heavy services (data onboarding, scanner interoperability testing, site validation). Transaction details commonly involve pilots (3?6 months), performance benchmarks on local cases, cybersecurity reviews, and multi-year contracts with add-ons (additional algorithms, seats, sites). Market trends include faster adoption of end-to-end digital workflows, expansion from single-organ tools to multi-cancer suites, tighter regulatory expectations, and convergence with multimodal diagnostics (WSI + genomics + clinical data) to improve risk stratification and treatment selection.
This report studies the global Digital Pathology AI-Assisted Diagnostic System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Digital Pathology AI-Assisted Diagnostic System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Digital Pathology AI-Assisted Diagnostic System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Digital Pathology AI-Assisted Diagnostic System total market, 2021-2032, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Digital Pathology AI-Assisted Diagnostic System total market, key domestic companies, and share, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by Type, CAGR, 2021-2032, (USD Million)
Global Digital Pathology AI-Assisted Diagnostic System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Digital Pathology AI-Assisted Diagnostic System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lunit, VUNO, Inc., Konfoong Bioinformation Tech, Techcyte, Hologic, Canon Medical, ANNALISE-AI PTY LTD, CellsVision, Dipath, Cytowiz Incorporated, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Digital Pathology AI-Assisted Diagnostic System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Digital Pathology AI-Assisted Diagnostic System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Equipment
- Software
- Cancer Detection & Classification
- Tumor Grading & Staging
- Biomarker & Companion Diagnostics
- Quantitative Pathology Analysis
- Screening & Triage
- On-premise
- Private Cloud (Hospital-owned Cloud)
- Public Cloud / SaaS
- Others
- Cervix
- Breast
- Gastrointestinal
- Other
- Lunit
- VUNO, Inc.
- Konfoong Bioinformation Tech
- Techcyte
- Hologic
- Canon Medical
- ANNALISE-AI PTY LTD
- CellsVision
- Dipath
- Cytowiz Incorporated
- Wuhan Zhongji Biotech
1. How big is the global Digital Pathology AI-Assisted Diagnostic System market?
2. What is the demand of the global Digital Pathology AI-Assisted Diagnostic System market?
3. What is the year over year growth of the global Digital Pathology AI-Assisted Diagnostic System market?
4. What is the total value of the global Digital Pathology AI-Assisted Diagnostic System market?
5. Who are the Major Players in the global Digital Pathology AI-Assisted Diagnostic System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Digital Pathology AI-Assisted Diagnostic System Introduction
1.2 World Digital Pathology AI-Assisted Diagnostic System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Digital Pathology AI-Assisted Diagnostic System Total Market by Region (by Headquarter Location)
1.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.3 China Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.4 Europe Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.5 Japan Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.6 South Korea Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.7 ASEAN Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.8 India Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Digital Pathology AI-Assisted Diagnostic System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.2 World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region
2.2.1 World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region (2021-2026)
2.2.2 World Digital Pathology AI-Assisted Diagnostic System Consumption Value Forecast by Region (2027-2032)
2.3 United States Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.4 China Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.5 Europe Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.6 Japan Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.7 South Korea Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.8 ASEAN Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.9 India Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
3 WORLD DIGITAL PATHOLOGY AI-ASSISTED DIAGNOSTIC SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Digital Pathology AI-Assisted Diagnostic System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Digital Pathology AI-Assisted Diagnostic System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Digital Pathology AI-Assisted Diagnostic System in 2025
3.2.3 Global Concentration Ratios (CR8) for Digital Pathology AI-Assisted Diagnostic System in 2025
3.3 Digital Pathology AI-Assisted Diagnostic System Company Evaluation Quadrant
3.4 Digital Pathology AI-Assisted Diagnostic System Market: Overall Company Footprint Analysis
3.4.1 Digital Pathology AI-Assisted Diagnostic System Market: Region Footprint
3.4.2 Digital Pathology AI-Assisted Diagnostic System Market: Company Product Type Footprint
3.4.3 Digital Pathology AI-Assisted Diagnostic System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison
4.2.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Digital Pathology AI-Assisted Diagnostic System Companies and Market Share, 2021-2026
4.3.1 United States Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026)
4.4 China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue and Market Share, 2021-2026
4.4.1 China Based Digital Pathology AI-Assisted Diagnostic System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026)
4.5 Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Equipment
5.2.2 Software
5.3 Market Segment by Type
5.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2021-2026)
5.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2027-2032)
5.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DIAGNOSTIC TASK
6.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Diagnostic Task: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Diagnostic Task
6.2.1 Cancer Detection & Classification
6.2.2 Tumor Grading & Staging
6.2.3 Biomarker & Companion Diagnostics
6.2.4 Quantitative Pathology Analysis
6.2.5 Screening & Triage
6.3 Market Segment by Diagnostic Task
6.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2021-2026)
6.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2027-2032)
6.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task (2027-2032)
7 MARKET ANALYSIS BY DEPLOYMENT MODEL
7.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Deployment Model
7.2.1 On-premise
7.2.2 Private Cloud (Hospital-owned Cloud)
7.2.3 Public Cloud / SaaS
7.2.4 Others
7.3 Market Segment by Deployment Model
7.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2021-2026)
7.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2027-2032)
7.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cervix
8.2.2 Breast
8.2.3 Gastrointestinal
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2021-2026)
8.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2027-2032)
8.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lunit
9.1.1 Lunit Details
9.1.2 Lunit Major Business
9.1.3 Lunit Digital Pathology AI-Assisted Diagnostic System Product and Services
9.1.4 Lunit Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lunit Recent Developments/Updates
9.1.6 Lunit Competitive Strengths & Weaknesses
9.2 VUNO, Inc.
9.2.1 VUNO, Inc. Details
9.2.2 VUNO, Inc. Major Business
9.2.3 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product and Services
9.2.4 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 VUNO, Inc. Recent Developments/Updates
9.2.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.3 Konfoong Bioinformation Tech
9.3.1 Konfoong Bioinformation Tech Details
9.3.2 Konfoong Bioinformation Tech Major Business
9.3.3 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product and Services
9.3.4 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Konfoong Bioinformation Tech Recent Developments/Updates
9.3.6 Konfoong Bioinformation Tech Competitive Strengths & Weaknesses
9.4 Techcyte
9.4.1 Techcyte Details
9.4.2 Techcyte Major Business
9.4.3 Techcyte Digital Pathology AI-Assisted Diagnostic System Product and Services
9.4.4 Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Techcyte Recent Developments/Updates
9.4.6 Techcyte Competitive Strengths & Weaknesses
9.5 Hologic
9.5.1 Hologic Details
9.5.2 Hologic Major Business
9.5.3 Hologic Digital Pathology AI-Assisted Diagnostic System Product and Services
9.5.4 Hologic Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic Recent Developments/Updates
9.5.6 Hologic Competitive Strengths & Weaknesses
9.6 Canon Medical
9.6.1 Canon Medical Details
9.6.2 Canon Medical Major Business
9.6.3 Canon Medical Digital Pathology AI-Assisted Diagnostic System Product and Services
9.6.4 Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Canon Medical Recent Developments/Updates
9.6.6 Canon Medical Competitive Strengths & Weaknesses
9.7 ANNALISE-AI PTY LTD
9.7.1 ANNALISE-AI PTY LTD Details
9.7.2 ANNALISE-AI PTY LTD Major Business
9.7.3 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product and Services
9.7.4 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.7.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.8 CellsVision
9.8.1 CellsVision Details
9.8.2 CellsVision Major Business
9.8.3 CellsVision Digital Pathology AI-Assisted Diagnostic System Product and Services
9.8.4 CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 CellsVision Recent Developments/Updates
9.8.6 CellsVision Competitive Strengths & Weaknesses
9.9 Dipath
9.9.1 Dipath Details
9.9.2 Dipath Major Business
9.9.3 Dipath Digital Pathology AI-Assisted Diagnostic System Product and Services
9.9.4 Dipath Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Dipath Recent Developments/Updates
9.9.6 Dipath Competitive Strengths & Weaknesses
9.10 Cytowiz Incorporated
9.10.1 Cytowiz Incorporated Details
9.10.2 Cytowiz Incorporated Major Business
9.10.3 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product and Services
9.10.4 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Cytowiz Incorporated Recent Developments/Updates
9.10.6 Cytowiz Incorporated Competitive Strengths & Weaknesses
9.11 Wuhan Zhongji Biotech
9.11.1 Wuhan Zhongji Biotech Details
9.11.2 Wuhan Zhongji Biotech Major Business
9.11.3 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product and Services
9.11.4 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Wuhan Zhongji Biotech Recent Developments/Updates
9.11.6 Wuhan Zhongji Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Digital Pathology AI-Assisted Diagnostic System Industry Chain
10.2 Digital Pathology AI-Assisted Diagnostic System Upstream Analysis
10.3 Digital Pathology AI-Assisted Diagnostic System Midstream Analysis
10.4 Digital Pathology AI-Assisted Diagnostic System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Digital Pathology AI-Assisted Diagnostic System Introduction
1.2 World Digital Pathology AI-Assisted Diagnostic System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Digital Pathology AI-Assisted Diagnostic System Total Market by Region (by Headquarter Location)
1.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.3 China Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.4 Europe Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.5 Japan Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.6 South Korea Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.7 ASEAN Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.3.8 India Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Digital Pathology AI-Assisted Diagnostic System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.2 World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region
2.2.1 World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region (2021-2026)
2.2.2 World Digital Pathology AI-Assisted Diagnostic System Consumption Value Forecast by Region (2027-2032)
2.3 United States Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.4 China Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.5 Europe Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.6 Japan Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.7 South Korea Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.8 ASEAN Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
2.9 India Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032)
3 WORLD DIGITAL PATHOLOGY AI-ASSISTED DIAGNOSTIC SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Digital Pathology AI-Assisted Diagnostic System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Digital Pathology AI-Assisted Diagnostic System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Digital Pathology AI-Assisted Diagnostic System in 2025
3.2.3 Global Concentration Ratios (CR8) for Digital Pathology AI-Assisted Diagnostic System in 2025
3.3 Digital Pathology AI-Assisted Diagnostic System Company Evaluation Quadrant
3.4 Digital Pathology AI-Assisted Diagnostic System Market: Overall Company Footprint Analysis
3.4.1 Digital Pathology AI-Assisted Diagnostic System Market: Region Footprint
3.4.2 Digital Pathology AI-Assisted Diagnostic System Market: Company Product Type Footprint
3.4.3 Digital Pathology AI-Assisted Diagnostic System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison
4.2.1 United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Digital Pathology AI-Assisted Diagnostic System Companies and Market Share, 2021-2026
4.3.1 United States Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026)
4.4 China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue and Market Share, 2021-2026
4.4.1 China Based Digital Pathology AI-Assisted Diagnostic System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026)
4.5 Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Equipment
5.2.2 Software
5.3 Market Segment by Type
5.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2021-2026)
5.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2027-2032)
5.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DIAGNOSTIC TASK
6.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Diagnostic Task: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Diagnostic Task
6.2.1 Cancer Detection & Classification
6.2.2 Tumor Grading & Staging
6.2.3 Biomarker & Companion Diagnostics
6.2.4 Quantitative Pathology Analysis
6.2.5 Screening & Triage
6.3 Market Segment by Diagnostic Task
6.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2021-2026)
6.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2027-2032)
6.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task (2027-2032)
7 MARKET ANALYSIS BY DEPLOYMENT MODEL
7.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Deployment Model
7.2.1 On-premise
7.2.2 Private Cloud (Hospital-owned Cloud)
7.2.3 Public Cloud / SaaS
7.2.4 Others
7.3 Market Segment by Deployment Model
7.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2021-2026)
7.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2027-2032)
7.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Digital Pathology AI-Assisted Diagnostic System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cervix
8.2.2 Breast
8.2.3 Gastrointestinal
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2021-2026)
8.3.2 World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2027-2032)
8.3.3 World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lunit
9.1.1 Lunit Details
9.1.2 Lunit Major Business
9.1.3 Lunit Digital Pathology AI-Assisted Diagnostic System Product and Services
9.1.4 Lunit Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lunit Recent Developments/Updates
9.1.6 Lunit Competitive Strengths & Weaknesses
9.2 VUNO, Inc.
9.2.1 VUNO, Inc. Details
9.2.2 VUNO, Inc. Major Business
9.2.3 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product and Services
9.2.4 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 VUNO, Inc. Recent Developments/Updates
9.2.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.3 Konfoong Bioinformation Tech
9.3.1 Konfoong Bioinformation Tech Details
9.3.2 Konfoong Bioinformation Tech Major Business
9.3.3 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product and Services
9.3.4 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Konfoong Bioinformation Tech Recent Developments/Updates
9.3.6 Konfoong Bioinformation Tech Competitive Strengths & Weaknesses
9.4 Techcyte
9.4.1 Techcyte Details
9.4.2 Techcyte Major Business
9.4.3 Techcyte Digital Pathology AI-Assisted Diagnostic System Product and Services
9.4.4 Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Techcyte Recent Developments/Updates
9.4.6 Techcyte Competitive Strengths & Weaknesses
9.5 Hologic
9.5.1 Hologic Details
9.5.2 Hologic Major Business
9.5.3 Hologic Digital Pathology AI-Assisted Diagnostic System Product and Services
9.5.4 Hologic Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic Recent Developments/Updates
9.5.6 Hologic Competitive Strengths & Weaknesses
9.6 Canon Medical
9.6.1 Canon Medical Details
9.6.2 Canon Medical Major Business
9.6.3 Canon Medical Digital Pathology AI-Assisted Diagnostic System Product and Services
9.6.4 Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Canon Medical Recent Developments/Updates
9.6.6 Canon Medical Competitive Strengths & Weaknesses
9.7 ANNALISE-AI PTY LTD
9.7.1 ANNALISE-AI PTY LTD Details
9.7.2 ANNALISE-AI PTY LTD Major Business
9.7.3 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product and Services
9.7.4 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.7.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.8 CellsVision
9.8.1 CellsVision Details
9.8.2 CellsVision Major Business
9.8.3 CellsVision Digital Pathology AI-Assisted Diagnostic System Product and Services
9.8.4 CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 CellsVision Recent Developments/Updates
9.8.6 CellsVision Competitive Strengths & Weaknesses
9.9 Dipath
9.9.1 Dipath Details
9.9.2 Dipath Major Business
9.9.3 Dipath Digital Pathology AI-Assisted Diagnostic System Product and Services
9.9.4 Dipath Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Dipath Recent Developments/Updates
9.9.6 Dipath Competitive Strengths & Weaknesses
9.10 Cytowiz Incorporated
9.10.1 Cytowiz Incorporated Details
9.10.2 Cytowiz Incorporated Major Business
9.10.3 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product and Services
9.10.4 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Cytowiz Incorporated Recent Developments/Updates
9.10.6 Cytowiz Incorporated Competitive Strengths & Weaknesses
9.11 Wuhan Zhongji Biotech
9.11.1 Wuhan Zhongji Biotech Details
9.11.2 Wuhan Zhongji Biotech Major Business
9.11.3 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product and Services
9.11.4 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Wuhan Zhongji Biotech Recent Developments/Updates
9.11.6 Wuhan Zhongji Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Digital Pathology AI-Assisted Diagnostic System Industry Chain
10.2 Digital Pathology AI-Assisted Diagnostic System Upstream Analysis
10.3 Digital Pathology AI-Assisted Diagnostic System Midstream Analysis
10.4 Digital Pathology AI-Assisted Diagnostic System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Digital Pathology AI-Assisted Diagnostic System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Digital Pathology AI-Assisted Diagnostic System Players in 2025
Table 12. World Digital Pathology AI-Assisted Diagnostic System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Digital Pathology AI-Assisted Diagnostic System Company Evaluation Quadrant
Table 14. Head Office of Key Digital Pathology AI-Assisted Diagnostic System Players
Table 15. Digital Pathology AI-Assisted Diagnostic System Market: Company Product Type Footprint
Table 16. Digital Pathology AI-Assisted Diagnostic System Market: Company Product Application Footprint
Table 17. Digital Pathology AI-Assisted Diagnostic System Mergers & Acquisitions Activity
Table 18. United States VS China Digital Pathology AI-Assisted Diagnostic System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 23. China Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 29. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task, (USD Million), 2021 & 2025 & 2032
Table 33. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Diagnostic Task (2021-2026) & (USD Million)
Table 34. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2027-2032) & (USD Million)
Table 35. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 37. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2027-2032) & (USD Million)
Table 38. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2021-2026) & (USD Million)
Table 40. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2027-2032) & (USD Million)
Table 41. Lunit Basic Information, Manufacturing Base and Competitors
Table 42. Lunit Major Business
Table 43. Lunit Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 44. Lunit Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lunit Recent Developments/Updates
Table 46. Lunit Competitive Strengths & Weaknesses
Table 47. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. VUNO, Inc. Major Business
Table 49. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 50. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. VUNO, Inc. Recent Developments/Updates
Table 52. VUNO, Inc. Competitive Strengths & Weaknesses
Table 53. Konfoong Bioinformation Tech Basic Information, Manufacturing Base and Competitors
Table 54. Konfoong Bioinformation Tech Major Business
Table 55. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 56. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Konfoong Bioinformation Tech Recent Developments/Updates
Table 58. Konfoong Bioinformation Tech Competitive Strengths & Weaknesses
Table 59. Techcyte Basic Information, Manufacturing Base and Competitors
Table 60. Techcyte Major Business
Table 61. Techcyte Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 62. Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Techcyte Recent Developments/Updates
Table 64. Techcyte Competitive Strengths & Weaknesses
Table 65. Hologic Basic Information, Manufacturing Base and Competitors
Table 66. Hologic Major Business
Table 67. Hologic Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 68. Hologic Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic Recent Developments/Updates
Table 70. Hologic Competitive Strengths & Weaknesses
Table 71. Canon Medical Basic Information, Manufacturing Base and Competitors
Table 72. Canon Medical Major Business
Table 73. Canon Medical Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 74. Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Canon Medical Recent Developments/Updates
Table 76. Canon Medical Competitive Strengths & Weaknesses
Table 77. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 78. ANNALISE-AI PTY LTD Major Business
Table 79. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 80. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 82. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 83. CellsVision Basic Information, Manufacturing Base and Competitors
Table 84. CellsVision Major Business
Table 85. CellsVision Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 86. CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. CellsVision Recent Developments/Updates
Table 88. CellsVision Competitive Strengths & Weaknesses
Table 89. Dipath Basic Information, Manufacturing Base and Competitors
Table 90. Dipath Major Business
Table 91. Dipath Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 92. Dipath Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Dipath Recent Developments/Updates
Table 94. Dipath Competitive Strengths & Weaknesses
Table 95. Cytowiz Incorporated Basic Information, Manufacturing Base and Competitors
Table 96. Cytowiz Incorporated Major Business
Table 97. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 98. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cytowiz Incorporated Recent Developments/Updates
Table 100. Cytowiz Incorporated Competitive Strengths & Weaknesses
Table 101. Wuhan Zhongji Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Wuhan Zhongji Biotech Major Business
Table 103. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 104. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Wuhan Zhongji Biotech Recent Developments/Updates
Table 106. Wuhan Zhongji Biotech Competitive Strengths & Weaknesses
Table 107. Global Key Players of Digital Pathology AI-Assisted Diagnostic System Upstream (Raw Materials)
Table 108. Global Digital Pathology AI-Assisted Diagnostic System Typical Customers
Table 1. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Digital Pathology AI-Assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Digital Pathology AI-Assisted Diagnostic System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Digital Pathology AI-Assisted Diagnostic System Players in 2025
Table 12. World Digital Pathology AI-Assisted Diagnostic System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Digital Pathology AI-Assisted Diagnostic System Company Evaluation Quadrant
Table 14. Head Office of Key Digital Pathology AI-Assisted Diagnostic System Players
Table 15. Digital Pathology AI-Assisted Diagnostic System Market: Company Product Type Footprint
Table 16. Digital Pathology AI-Assisted Diagnostic System Market: Company Product Application Footprint
Table 17. Digital Pathology AI-Assisted Diagnostic System Mergers & Acquisitions Activity
Table 18. United States VS China Digital Pathology AI-Assisted Diagnostic System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Digital Pathology AI-Assisted Diagnostic System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 23. China Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Digital Pathology AI-Assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Digital Pathology AI-Assisted Diagnostic System Revenue Market Share (2021-2026)
Table 29. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task, (USD Million), 2021 & 2025 & 2032
Table 33. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Diagnostic Task (2021-2026) & (USD Million)
Table 34. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task (2027-2032) & (USD Million)
Table 35. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Digital Pathology AI-Assisted Diagnostic System Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 37. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model (2027-2032) & (USD Million)
Table 38. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2021-2026) & (USD Million)
Table 40. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application (2027-2032) & (USD Million)
Table 41. Lunit Basic Information, Manufacturing Base and Competitors
Table 42. Lunit Major Business
Table 43. Lunit Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 44. Lunit Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lunit Recent Developments/Updates
Table 46. Lunit Competitive Strengths & Weaknesses
Table 47. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. VUNO, Inc. Major Business
Table 49. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 50. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. VUNO, Inc. Recent Developments/Updates
Table 52. VUNO, Inc. Competitive Strengths & Weaknesses
Table 53. Konfoong Bioinformation Tech Basic Information, Manufacturing Base and Competitors
Table 54. Konfoong Bioinformation Tech Major Business
Table 55. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 56. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Konfoong Bioinformation Tech Recent Developments/Updates
Table 58. Konfoong Bioinformation Tech Competitive Strengths & Weaknesses
Table 59. Techcyte Basic Information, Manufacturing Base and Competitors
Table 60. Techcyte Major Business
Table 61. Techcyte Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 62. Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Techcyte Recent Developments/Updates
Table 64. Techcyte Competitive Strengths & Weaknesses
Table 65. Hologic Basic Information, Manufacturing Base and Competitors
Table 66. Hologic Major Business
Table 67. Hologic Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 68. Hologic Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic Recent Developments/Updates
Table 70. Hologic Competitive Strengths & Weaknesses
Table 71. Canon Medical Basic Information, Manufacturing Base and Competitors
Table 72. Canon Medical Major Business
Table 73. Canon Medical Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 74. Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Canon Medical Recent Developments/Updates
Table 76. Canon Medical Competitive Strengths & Weaknesses
Table 77. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 78. ANNALISE-AI PTY LTD Major Business
Table 79. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 80. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 82. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 83. CellsVision Basic Information, Manufacturing Base and Competitors
Table 84. CellsVision Major Business
Table 85. CellsVision Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 86. CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. CellsVision Recent Developments/Updates
Table 88. CellsVision Competitive Strengths & Weaknesses
Table 89. Dipath Basic Information, Manufacturing Base and Competitors
Table 90. Dipath Major Business
Table 91. Dipath Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 92. Dipath Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Dipath Recent Developments/Updates
Table 94. Dipath Competitive Strengths & Weaknesses
Table 95. Cytowiz Incorporated Basic Information, Manufacturing Base and Competitors
Table 96. Cytowiz Incorporated Major Business
Table 97. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 98. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cytowiz Incorporated Recent Developments/Updates
Table 100. Cytowiz Incorporated Competitive Strengths & Weaknesses
Table 101. Wuhan Zhongji Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Wuhan Zhongji Biotech Major Business
Table 103. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product and Services
Table 104. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Wuhan Zhongji Biotech Recent Developments/Updates
Table 106. Wuhan Zhongji Biotech Competitive Strengths & Weaknesses
Table 107. Global Key Players of Digital Pathology AI-Assisted Diagnostic System Upstream (Raw Materials)
Table 108. Global Digital Pathology AI-Assisted Diagnostic System Typical Customers
LIST OF FIGURES
Figure 1. Digital Pathology AI-Assisted Diagnostic System Picture
Figure 2. World Digital Pathology AI-Assisted Diagnostic System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Digital Pathology AI-Assisted Diagnostic System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 13. Digital Pathology AI-Assisted Diagnostic System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Digital Pathology AI-Assisted Diagnostic System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Digital Pathology AI-Assisted Diagnostic System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Digital Pathology AI-Assisted Diagnostic System Markets in 2025
Figure 27. United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type in 2025
Figure 31. Equipment
Figure 32. Software
Figure 33. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type (2021-2032)
Figure 34. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task, (USD Million), 2021 & 2025 & 2032
Figure 35. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task in 2025
Figure 36. Cancer Detection & Classification
Figure 37. Tumor Grading & Staging
Figure 38. Biomarker & Companion Diagnostics
Figure 39. Quantitative Pathology Analysis
Figure 40. Screening & Triage
Figure 41. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task (2021-2032)
Figure 42. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 43. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model in 2025
Figure 44. On-premise
Figure 45. Private Cloud (Hospital-owned Cloud)
Figure 46. Public Cloud / SaaS
Figure 47. Others
Figure 48. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model (2021-2032)
Figure 49. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application in 2025
Figure 51. Cervix
Figure 52. Breast
Figure 53. Gastrointestinal
Figure 54. Other
Figure 55. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application (2021-2032)
Figure 56. Digital Pathology AI-Assisted Diagnostic System Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Digital Pathology AI-Assisted Diagnostic System Picture
Figure 2. World Digital Pathology AI-Assisted Diagnostic System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Digital Pathology AI-Assisted Diagnostic System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 13. Digital Pathology AI-Assisted Diagnostic System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Digital Pathology AI-Assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Digital Pathology AI-Assisted Diagnostic System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Digital Pathology AI-Assisted Diagnostic System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Digital Pathology AI-Assisted Diagnostic System Markets in 2025
Figure 27. United States VS China: Digital Pathology AI-Assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Digital Pathology AI-Assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Digital Pathology AI-Assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type in 2025
Figure 31. Equipment
Figure 32. Software
Figure 33. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Type (2021-2032)
Figure 34. World Digital Pathology AI-Assisted Diagnostic System Market Size by Diagnostic Task, (USD Million), 2021 & 2025 & 2032
Figure 35. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task in 2025
Figure 36. Cancer Detection & Classification
Figure 37. Tumor Grading & Staging
Figure 38. Biomarker & Companion Diagnostics
Figure 39. Quantitative Pathology Analysis
Figure 40. Screening & Triage
Figure 41. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Diagnostic Task (2021-2032)
Figure 42. World Digital Pathology AI-Assisted Diagnostic System Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 43. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model in 2025
Figure 44. On-premise
Figure 45. Private Cloud (Hospital-owned Cloud)
Figure 46. Public Cloud / SaaS
Figure 47. Others
Figure 48. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Deployment Model (2021-2032)
Figure 49. World Digital Pathology AI-Assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application in 2025
Figure 51. Cervix
Figure 52. Breast
Figure 53. Gastrointestinal
Figure 54. Other
Figure 55. World Digital Pathology AI-Assisted Diagnostic System Market Size Market Share by Application (2021-2032)
Figure 56. Digital Pathology AI-Assisted Diagnostic System Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
